Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy
June 14 2023 - 9:49AM
Specialty cancer diagnostics company Precipio, Inc. leveraged
its proprietary HemeScreen Cytopenia panel as part of the
diagnostic process for molecular identification of driver mutations
in a patient with a history of transfusion-dependent anemia and
experiencing progressive weakness and neurological symptoms. The
findings point to an underlying myeloid stem cell disorder,
including a myelodysplastic syndrome and possibly a higher-grade
myeloid neoplasm.
A major advantage in the case work-up using the
Omnia methodology was the ability to detect these driver mutations
using only a peripheral blood sample and not requiring a further
bone marrow biopsy to confirm pathology suspicions. This enabled a
more comprehensive and rapid result for the clinician to act upon
to manage patient care.
In this case, the detection of ASXL1 and WT1
mutations are associated with a poor prognosis, further reinforcing
the need for accuracy and speed in this case work-up.
“Providing a comprehensive diagnosis with
minimally invasive sample procurement is critical to informing
treatment decisions,” said Ilan Danieli, Precipio CEO. “Not only
does this enable our lab to deliver a rapid diagnosis, but greatly
improves patient compliance from those who would otherwise need a
more invasive, follow up bone marrow biopsy to confirm
results.”
About Precipio
Precipio has built a platform designed to
eradicate the problem of misdiagnosis by harnessing the intellect,
expertise and technology developed within academic institutions and
delivering quality diagnostic information to physicians and their
patients worldwide, as well as proprietary products that serve
laboratories worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics
and treatment, Precipio offers a new standard of diagnostic
accuracy enabling the highest level of patient care. For more
information, please visit www.precipiodx.com.
Please follow us on LinkedIn, Twitter
@PrecipioDx and on Facebook.
Inquiries:contact@precipiodx.com+1-203-787-7888
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Jul 2023 to Jul 2024